Diabetes complications

Diabetes duration and advanced diabetes-related complications in lower-extremity vs coronary revascularization

J Clin Endocrinol MetabPublished Cross-sectional study

Authors' conclusion

Patients undergoing revascularization for LEAD exhibited a longer diabetes duration than those undergoing revascularization for CAD. They also had a higher prevalence of advanced diabetes-related complications, even after adjustment for diabetes duration.

Study context

Population
Patients with diabetes undergoing revascularization for lower extremity artery disease (LEAD) or coronary artery disease (CAD), registered in a prospective multicenter study
Participants
5,808 patients
Exposure
Revascularization for LEAD vs for CAD
Outcome
Diabetes-related burden: diabetes duration, HbA1c and advanced diabetes-related complications
Follow-up
At index revascularization
Methodological detailsregistered in a prospective multicenter study
  • Registered in a prospective multicenter study

Main finding

As reported in the abstract

  • LEAD had a longer diabetes duration and a higher prevalence of advanced complications than CAD
  • HbA1c at revascularization did not significantly differ between the groups

Observational data: associations, not effects.

Further findings

OutcomeAdjusted prevalence ratioP value
Proliferative retinopathy, adjusted for diabetes duration1.57 (95% CI 1.41–1.75)P < 0.001
Loss of protective sensation, adjusted for diabetes duration2.39 (CI 1.82–3.13)P < 0.001
Dialysis-dependent renal failure, adjusted for diabetes duration2.12 (CI 1.82–3.13)P < 0.001
  • Dialysis-dependent renal failure, adjusted for diabetes duration: CI printed identical to that for loss of protective sensation

Original publication

Diabetes duration and advanced diabetes-related complications in lower-extremity vs coronary revascularization. J Clin Endocrinol Metab. Published 25 September 2026. doi:10.1210/clinem/dgag387

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.